Pular para o conteúdo

Interações medicamentosas

Fingolimod + Liposomal doxorubicin

Gravidade: Grave

Fingolimod and Liposomal doxorubicin: major interaction.

Última atualização

Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.

O conteúdo clínico desta página está disponível apenas em inglês.

Resumo

Both agents suppress immune function, so combined use may increase the risk of serious infections. Fingolimod lowers circulating lymphocytes, adding to chemotherapy-related myelosuppression.

O que esta interação significa em palavras simples

Fingolimod and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Fingolimod belongs to Central Nervous System; Liposomal doxorubicin belongs to Oncology.

Nível de evidência: Low

Por que acontece

Additive immunosuppression from lymphocyte sequestration by fingolimod and myelosuppression by doxorubicin.

O que fazer

Avoid concurrent use where possible and monitor blood counts and signs of infection. Consider interrupting fingolimod during chemotherapy.

O que perguntar ao farmacêutico

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Para assinantes do Pro+

Desbloqueie a página completa

Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Fingolimod e Liposomal doxorubicin, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Experimente o Pro+ grátis por 7 dias na web. Sem cartão.

Perguntas frequentes

Can I take Fingolimod with Liposomal doxorubicin?

MediHelp rates the interaction as major. Fingolimod and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents suppress immune function, so combined use may increase the risk of serious infections. Fingolimod lowers circulating lymphocytes, adding to chemotherapy-related myelosuppression.

How serious is the interaction between Fingolimod and Liposomal doxorubicin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible and monitor blood counts and signs of infection. Consider interrupting fingolimod during chemotherapy.

What other medicines interact with Liposomal doxorubicin?

MediHelp also lists interactions of Liposomal doxorubicin with, for example, Dengue vaccine, Belatacept, Cyclosporine. The full list is on the Liposomal doxorubicin page.

Monografias completas, posologia e verificador de interações no app MediHelp

Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.

Explorar de A a Z · Interações medicamentosas

Baixar o app Entrar